JACIE and Quality Management in HSCT: Implications for Nursing

Abstract

Laboratory medicine, along with the airline industry, has a long history of utilising quality management systems. It took until 1999 for The Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT), known as JACIE, to be established as an accreditation system in the field of haematopoietic stem cell transplantation (HSCT). The aim was to create a standardised system of accreditation to be officially recognised across Europe and was based on the accreditation standards established by the US-based Foundation for the Accreditation of Cellular Therapy (FACT). Since the concept of JACIE was originally launched, many European centres have applied for initial accreditation with other centres gaining reaccreditation for the 2nd or 3rd time. Transplant units, outside of Europe, have accepted the importance of the JACIE Standards, with units in South Africa, Singapore and Saudi Arabia also gaining accreditation. There is evidence that both donor and patient care have improved within the accredited centres (

Outpatient allogeneic hematopoietic stem-cell transplantation: a review

“…The Foundation for the Accreditation of Cellular Therapy (FACT) in America and the Joint Accreditation Committee ISCT-Europe & EBMT (JACIE) have established international standards for the provision of quality medical, nursing, and laboratory practice in the field of HSCT transplantation. 46 Information on the characteristics that the clinical unit should have is included in section B2 of the FACT standards manual in its seventh edition (March 2018). FACT considers that these characteristics may vary according to the number and type of transplant (autologous or allogeneic) performed, the cell source, epidemiological factors influencing the prevalence of opportunistic infections, and economic considerations.…”